Michael Setzen, MD
Otolaryngology · Great Neck, NYNPI 1356381628
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $59,617 of the $69,416 with a category attached, or 85.9%. 17 manufacturers reported payments, led by Aerin Medical Inc. at 58.1% of the total. 2025 is the largest year on record at $39,588, more than ten times the $414 reported in 2019. Among otolaryngology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 155 payments — averaging $447.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$40K
- Stryker$19K
- Regeneron$5K
- Medtronic$1K
- Optinose US, Inc.$796
- Neurent Medical Limited$792
- plus $2K from 11 others
What the payments were for
- Consulting fees$59,61786%
- Speaking & faculty fees$9501%
- Travel & lodging$9851%
- Food & beverage$7,76511%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 31 | $40,344 |
| Stryker | 30 | $18,849 |
| Regeneron | 3 | $5,142 |
| Medtronic(2 entities) | 3 | $1,224 |
| Optinose US, Inc. | 31 | $796 |
| Neurent Medical Limited | 6 | $792 |
| Sanofi | 19 | $705 |
| Intersect ENT, Inc. | 4 | $490 |
| Regeneron Healthcare Solutions, Inc. | 11 | $396 |
| Genentech USA, Inc. | 1 | $150 |
| Inspire Medical Systems, Inc. | 3 | $150 |
| GSK | 6 | $144 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Merck | 2 | $45 |
| Integra Lifesciences Corporation | 1 | $44 |
| Acclarent, Inc | 2 | $26 |
| Chiesi USA, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$39,337
- XPRESS ENT DILATION SYSTEM$15,802
- CLARIFIX CRYOTHERAPY DEVICE$15,000
- LATERA$14,500
- DUPIXENT$5,601
- SCOPIS ENT$1,791
- RHINAER STYLUS$1,462
- STRAIGHTSHOT$950
- NEUROMARK Device$658
- ENTELLUS MEDICAL FOCESS SINUSCOPE$500
- ORTHOMAP$500
- XPRESS LOPROFILE$500
- NEUROMARK Radiofrequency Console$374
- PROPEL$321
- NEUROMARK Radiofrequency Generator$284
- NUVENT$250
- ENTELLUS - OFFICE SINUS PROCEDURE PACK$157
- XOLAIR$150
- Navigation CUBE$149
- Inspire$121
How this compares
$69,416 in reported general payments places this provider in the 95th percentile of 701 otolaryngology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XhanceFluticasone Propionate | 11 | $7,026 |
| Fluticasone Propionate | 81 | $2,024 |
| Omeprazole | 102 | $1,678 |
| Azelastine Hcl | 30 | $1,218 |
| Ipratropium Bromide | 39 | $1,207 |
| Famotidine | 57 | $779 |
| Methylprednisolone | 46 | $312 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 33 | $248 |
| Azithromycin | 37 | $88 |
| Montelukast Sodium | 11 | $69 |
| Amoxicillin | 17 | $65 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Optinose US, Inc.Xhance | $796 | $7,02611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 701 otolaryngology providers in New York.
Other otolaryngology in Great Neck
- Karen Haunss-SapinskiGreat Neck$20K
- Robert KellmanSyracuse$2.5M
- Roheen RaithathaNew York$830K
- Nora PerkinsAlbany$300K
- Moshe EphratNew Hyde Park$250K
- Gavin SetzenAlbany$243K
- Habibullah JamalRye Brook$179K
- Albert JenFlushing$171K
- Dennis KrausNew York$159K
- Nitin BhatiaWhite Plains$120K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.